However, the role of IL-6 on ICIs treatment for gastric adenocarcinoma (GAC) and esophageal squamous cell carcinoma (ESCC) — two of the most prevalent and aggressive upper gastrointestinal malignancies — remains unclear. The gene discussed is IL6; the disease is esophageal squamous cell carcinoma.